Knockdown of PTK2 in HCC cells reduces in vitro and in vivo tumorigenicity by inducing G2/M arrest and apoptosis, decreasing anchorage-independent growth, and modulating the expression of cancer-promoting genes 24. Here, PTK2 is linked to hepatocellular carcinoma.